Disase-specific survival | Metastasis-free survival | Recurrence-free survival | |||||
---|---|---|---|---|---|---|---|
Marker expression | Patients (n) | 5-Year survival (%) | P | 5-Year survival (%) | P | 5-Year survival (%) | P |
PDGF-A | |||||||
Low | 54 | 60 | 0.035 | 74 | 0.007 | 79 | 0.012 |
High | 58 | 52 | 51 | 55 | |||
Missing | 3 | ||||||
PDGF-B | |||||||
Low | 44 | 68 | 0.006 | 78 | 0.003 | 82 | 0.015 |
High | 68 | 48 | 52 | 56 | |||
Missing | 3 | ||||||
PDGF-C | |||||||
Low | 31 | 71 | 0.032 | 68 | 0.214 | 68 | 0.564 |
High | 80 | 50 | 61 | 65 | |||
Missing | 4 | ||||||
PDGF-D | |||||||
Low | 73 | 67 | 0.003 | 70 | 0.051 | 77 | 0.002 |
High | 40 | 34 | 49 | 42 | |||
Missing | 2 | ||||||
PDGFR-α | |||||||
Low | 69 | 67 | 0.002 | 74 | 0.002 | 77 | 0.011 |
High | 43 | 38 | 42 | 45 | |||
Missing | 3 | ||||||
PDGFR-β | |||||||
Low | 85 | 64 | 0.029 | 72 | 0.002 | 69 | 0.825 |
High | 24 | 32 | 35 | 58 | |||
Missing | 6 | ||||||
VEGF-A | |||||||
Low | 60 | 65 | 0.001 | 75 | 0.001 | 77 | 0.002 |
High | 51 | 43 | 48 | 51 | |||
Missing | 4 | ||||||
VEGF-C | |||||||
Low | 69 | 55 | 0.476 | 68 | 0.083 | 68 | 0.232 |
High | 38 | 60 | 56 | 63 | |||
Missing | 8 | ||||||
VEGF-D | |||||||
Low | 84 | 57 | 0.131 | 67 | 0.081 | 70 | 0.177 |
High | 29 | 50 | 51 | 55 | |||
Missing | 2 | ||||||
VEGFR-1 | |||||||
Low | 67 | 63 | 0.002 | 77 | <0.001 | 72 | 0.036 |
High | 44 | 46 | 43 | 58 | |||
Missing | 4 | ||||||
VEGFR-2 | |||||||
Low | 78 | 58 | 0.332 | 67 | 0.189 | 71 | 0.240 |
High | 28 | 52 | 53 | 57 | |||
Missing | 9 | ||||||
VEGFR-3 | |||||||
Low | 75 | 60 | 0.053 | 70 | 0.008 | 70 | 0.159 |
High | 34 | 45 | 46 | 57 | |||
Missing | 6 | ||||||
FGF2 | |||||||
Low | 75 | 61 | 0.033 | 66 | 0.214 | 70 | 0.648 |
High | 35 | 49 | 56 | 67 | |||
Missing | 6 | ||||||
FGFR-1 | |||||||
Low | 83 | 58 | 0.460 | 64 | 0.411 | 66 | 0.768 |
High | 26 | 47 | 55 | 71 | |||
Missing | 6 |